Aquarius Surgical Technologies Inc. Stock
Equities
ASTI
CA03842P1009
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | +100.00% | 0.00% | +300.00% |
Sales 2022 | 328K 239K | Sales 2023 | 204K 149K | Capitalization | 276K 201K |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 14.5 x |
Net Debt 2022 | 3.08M 2.25M | Net Debt 2023 | 3.39M 2.47M | EV / Sales 2023 | 18 x |
P/E ratio 2022 |
-1.93
x | P/E ratio 2023 |
-0.38
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | +100.00% | ||
Current month | +14.29% | ||
1 month | +14.29% | ||
3 months | +300.00% | ||
6 months | +300.00% | ||
Current year | +300.00% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Machika
CEO | Chief Executive Officer | - | - |
Lorne MacFarlane
DFI | Director of Finance/CFO | - | - |
David Hennigar
CHM | Chairman | 84 | 91-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hennigar
CHM | Chairman | 84 | 91-12-31 |
Director/Board Member | - | 15-12-31 | |
Director/Board Member | 64 | - |
1st Jan change | Capi. | |
---|---|---|
+300.00% | 804K | |
+6.62% | 209B | |
+2.05% | 175B | |
+9.94% | 131B | |
+17.88% | 99.98B | |
-1.06% | 61.12B | |
+14.68% | 52.34B | |
-4.15% | 46.5B | |
-1.23% | 39.24B | |
+9.89% | 38.47B |
- Stock Market
- Equities
- ASTI Stock